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Objective: An early differential diagnosis is mandatory when facing a patient with clinical shock of un-
clear aetiology, in order to guide proper treatment. We assessed if the expired CO2 measurement and
alveolar-arterial CO2 calculation could improve the differential diagnosis of shock during its initial
presentation, particularly in separating pulmonary embolism from other causes of shock.
Methods: We analysed the charts of 12 patients who presented with clinical shock and had end-tidal CO2
(EtCO2) and arterial CO2 partial pressure (PaCO2) measurements.
Results: In cases with pulmonary embolism-related shock (n ¼ 3), the gradient between PaCO2 and EtCO2
was increased (37 vs 0.2 mmHg). There was a similar trend for a higher PaCO2 value (60 vs 32.2 mmHg)
and a lower EtCO2 value (23 vs 32 mmHg).
Conclusion: An initial CO2 measurement might be an easily available tool for the early diagnostic work-
up of clinical shock.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
When managing clinical shock, either in the pre-hospital or
emergency department setting, it is always a challenge to assess the
appropriate diagnosis, treatment, and prognosis as rapidly as
possible. Physicians dealing with respiratory emergencies and life
threatening clinical situations may encounter difﬁcult situations
where the initial clinical signs, symptoms, and monitoring do not
indicate any clear aetiology while the patient's vital signs continue
to deteriorate. Moreover, diagnostic tests like echocardiography or
spiral CT of the chest may not be immediately accessible due to the
patient's instability or local conditions.
The CO2 measurement can show a correlation between
decreased CO2 transport in the blood and hemodynamic compro-
mise. The measurement of either expired CO2 or arterial CO2, or the
difference between these two measures, has been studied since the
1970s as a surrogate marker of shock, but the potential of this
marker for improving the diagnostic or prognostic evaluation of
shock has yet to be conﬁrmed in the clinical literature [1]. Massive
pulmonary embolism (PE) results in low CO2 transport, due toint-Luc, Av Hippocrate, Brus-
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effect (increase in poorly perfused, but well ventilated lung areas).
Both conditions contribute theoretically to additional decreased
expired CO2 elimination at the mouth and an increased difference
between arterial and alveolar CO2 [2,3]. We aimed to assess if
expired CO2 and/or alveolar-arterial CO2 gradient measurements
can improve the differential diagnosis of shock by distinguishing PE
from other aetiologies during the early clinical presentation in an
emergency setting.2. Methods
We analysed a non-consecutive and monocentric case series.
Patients were considered for analysis following three conditions:
they presented with arterial hypotension (deﬁned as systolic
arterial blood pressure <90 mmHg) and clinical signs of circulatory
shock (neurological alteration, marbled skin, cyanosis, prolonged
capillary reﬁll time); there was no clear aetiology at the time of
admission to the emergency department or the pre-hospital
setting; end-tidal CO2 (EtCO2), from a commercial time-based
capnography, and arterial CO2 partial pressure (PaCO2) were
measured at admission, before the establishment of a ﬁnal diag-
nosis. Both spontaneously ventilating and invasively ventilated
patients were included.
All patients underwent a cardiac echography as ﬁrst bedsidender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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standard procedures. In particular, a spiral CT was used to
conﬁrm PE when patient's clinical condition was more stable.
The end point of this case series was the correlation between the
initial P(aEt)CO2 gradient and the diagnosis of PE induced-shock.
3. Results
The expired CO2 was measured in 12 patients admitted to the
emergency department with circulatory shock. Their main initial
characteristics, the initial management, and ﬁnal diagnosis are
presented in Table 1. The median age was 66 years and the sex ratio
was 1. Massive PE was the cause of the shock in three patients.
Other shocks were deﬁned as septic (n ¼ 4), cardiogenic (n ¼ 2),
obstructive due to aortic root dissection and secondary pericardial
tamponade (n ¼ 2), and neurogenic (n ¼ 1). The ﬁnal aetiologies of
the shocks were conﬁrmed by computed tomography pulmonary
angiography (PE), medullar MRI (vasoplegia by medullary section),
isolation of microbiological pathogens (sepsis), and cardiac
echography (aortic root dissection, cardiogenic shock). At the time
of expired CO2 measurement, all patients required high oxygen
supplement. Seven patients were spontaneously ventilating and
ﬁve were mechanically ventilated, for cardiorespiratory arrest
(n ¼ 3), respiratory failure (n ¼ 1), and coma from neurological
origin (n ¼ 1). No patient suffered from chronic respiratory failure.
The patients' CO2-related measurements and characteristics are
presented in Table 2 for patients with and without PE. The PaCO2
was higher and the EtCO2 lower in cases with PE, but the differ-
ences were not signiﬁcant. However, patients with PE-related
shock had a signiﬁcant increase in the P(aEt)CO2 gradient (37 vs
0.2 mmHg). Jugular venous distention was observed in the three
patients with massive PE and in one patient with shock due to a
different aetiology. Survival and mechanical ventilation require-
ment rates did not signiﬁcantly differ between the two groups.
4. Discussion
We presented a short series of 12 patients in circulatory shock
without a clear aetiology at the pre-hospital or emergency
department admission. The mean difference between arterial and
expired CO2 (the P(aEt)CO2 gradient) was 37 mmHg in the three
patients with a massive PE and 0.2 mmHg in the nine patients with
another diagnosis. The isolated EtCO2 measurement showed a
similar trend to lower values in patients with PE (23 vs 32 mmHg)Table 1
Patients' characteristics, initial vital signs, established diagnosis, and outcome.
Age Sex Arterial pressure
(mmHg)
Heart rate
(/min)
GCS pH Lactate
(mmol/l)
Initial PaCO2
(mmHg)
Initia
(mm
1 61 M 70/50 155 3 7.1 11.4 37 39
2 47 F 70/40 140 15 7.3 5.9 38 45
3 49 M 50/30 50 3 6.69 18 65 37
4 73 M 80/40 140 14 7.41 10.6 14 20
5 73 F 45/30 44 3 7.4 3.2 23 22
6 30 F 75/50 123 3 6.82 13.1 83 20
7 66 F 65/43 70 3 7.23 11.5 54 44
8 67 M 50/30 41 14 7.47 3.7 29 28
9 54 M 75/30 40 15 7.3 0.8 20 21
10 69 F 70/30 108 14 7.46 1.1 32 12
11 66 F 70/45 90 14 7.45 1.4 37 24
12 69 M 60/35 48 3 7.4 10 38 45
Abbreviations e GCS: Glasgow Coma Scale; PE: pulmonary embolism; STEMI: ST-elevatiand the isolated arterial PaCO2 showed a similar trend to higher
values (60 vs 32 mmHg). Under the reserve of this small sample, an
early and easy initial CO2 measurement might help the physician in
the diagnostic work-up of a severe and unclear shock.
The calculation of alveolar dead space volume using capnog-
raphy was previously shown to be of interest in the diagnosis of PE
when combined with pretest clinical probability and D-dimer re-
sults [4,5]. Kline et al. also demonstrated a correlation between the
increase in alveolar dead space volume and the severity of pul-
monary vascular occlusion, by means of the vascular defect per-
centage on perfusion lung scans [6]. However, this literature refers
to patients with adequate blood pressure [4e6]. Capnography was
also shown to be a reliable noninvasive alternative in monitoring
the efﬁcacy of thrombolysis in massive PE when the diagnosis has
been established [7,8]. Our results extend the application range of
the expired CO2 measurement by suggesting its potential in the
assessment of clinical shock of unclear aetiology.
Clinical signs guide the physician in the initial management of
shock. In the patient data analysed, obstructive shocks due to
massive PE were signiﬁcantly linked with the presence of jugular
vein distension. This ﬁnding was potentially interesting; however,
large prospective data already proved the lack of speciﬁcity of ju-
gular vein assessment in PE [9]. Thus, the CO2 measurement was
the only paraclinical parameter of interest identiﬁed in these cases
of shock.
There ismajor potential interest for capnographymeasurements
in patients with shock when the early diagnosis is difﬁcult to
establish. Even if this difﬁculty might subjectively depend on the
physician's experience, we consider our short series as represen-
tative of the most challenging urgent clinical situations physicians
must face, in terms of rare and complex diagnoses (like aortic root
dissection with tamponade) or clinical severity (like cardiac arrest,
severe acidosis with pH < 7.0, and requirement of mechanical
ventilation). Any easily obtained EtCO2 or P(AEt)CO2 value might
be useful in those particularly stressful situations, as it could reﬁne
the differential diagnosis and point towards the next diagnostic
tests to realize.
Our case series has major limitations. First, although it was of a
prospective nature, the results were retrospectively analysed. In-
clusions were non-consecutive, implying a selection bias. Second,
our small sample of patients prevents generalization of the results.
Third, we have interpretation bias, as our 2 groups are not repre-
sentative of the same population, as proven by the difference in
mortality rates or pH values.l EtCO2
Hg)
Initial P(A-Et) CO2
gradient (mmHg)
Diagnosis Outcome at
30 days
2 Septic shock Death
7 Septic shock Death
28 Massive PE Survival
6 Septic shock Death
1 Aortic root dissection &
tamponade
Survival
63 Massive PE Survival
10 Cardiogenic shock (STEMI) Death
1 Aortic root dissection &
tamponade
Survival
1 Cardiogenic shock (beta-
blocker overdose)
Survival
20 Massive PE Survival
13 Septic shock Survival
7 Neurogenic shock (medullary
C1eC2 section)
death
on myocardial infarction. PaCO2: arterial CO2 partial pressure. EtCO2: End-tidal CO2.
Table 2
Patients' CO2-related measurements.
Patients with pulmonary embolism (n ¼ 3) Patients without pulmonary embolism (n ¼ 9)
Patients' characteristics
Mechanical ventilation required 2 3
Jugular vein distension 3 1
pH (mean) 6.99 ± 0.41 7.34 ± 0.12
survival 3 4
CO2 analysis (mmHg, mean ± SD)
PaCO2 60 ± 26 32 ± 12
EtCO2 23 ± 13 32 ± 11
(Pa-Et)CO2 gradient 37 ± 23 0 ± 7
Abbreviations-PaCO2: arterial partial CO2 pressure; EtCO2: end-tidal CO2.
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to focus on the potential clinical value for physicians facing life-
threatening clinical situations to measure P(AEt)CO2 in cases of
shock, especially if the diagnosis is initially challenging. Our data
are far too limited in order to draw any clinical conclusion. Our
results could however question if an initial P(AEt)CO2 difference
remaining under the normal range (less than 5 mmHg) could guide
the clinician to another diagnosis than PE in case of a clinical shock
of unclear aetiology at the time of admission.
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